Endocrine Disruptor Risk Characterization: An EPA Perspective

By Fenner-Crisp P.A.  

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 1, 1997-08 ,pp. : 70-73

Academic Press

Access to resources Recommend Favorite

Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A

By  

Current Cancer Drug Targets, Vol. 10, Iss. 2, 2010-03 ,pp. : 147-154

Bentham Science Publishers

Access to resources Recommend Favorite

Endocrine Disruptor Agent Nonyl Phenol Exerts An Estrogen-like Transcriptional Activity on Estrogen Receptor Positive Breast Cancer Cells

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 630-640

Bentham Science Publishers

Access to resources Recommend Favorite

Endocrine Disruptors and Human Health

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 9, 2010-08 ,pp. : 846-855

Bentham Science Publishers

Access to resources Recommend Favorite

Human developmental exposure to endocrine active compounds

By Foster W.G.   Hughes C.L.   Chan S.   Platt L.  

Environmental Toxicology and Pharmacology, Vol. 12, Iss. 2, 2002-09 ,pp. : 75-81

Elsevier

Access to resources Recommend Favorite